gemcitabine
information and resources from the National Cancer Institute
Gemzar
For use in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer.
Eli Lilly Aug 25 1998
Gemzar
Treatment of patients with locally advanced (nonresectable stage II or III) or metastatic (stage IV) adenocarcinoma of the pancreas. Indicated for first-line treatment and for patients previously treated with a 5-fluorouracil-containing regimen.
Eli Lilly May 15 1996
|
|
|
|
news articles
S KOREAN GOVT STOPS IMPORT OF GENERIC ANTI-CANCER DRUG Mar 27, 2006
TMCnet The ban on gemcitabine hydrochloride is to take effect until the conclusion of the related investigation on November 10, according to the Korea Trade Commission ...
Gemzar®/Platinol® Superior to VePesid®/Platinol® in Non-Small ... Mar 29, 2006
Cancer Consultants (press release), According to an article recently published in Lung Cancer, the chemotherapy combination consisting of Gemzar® (gemcitabine) plus Platinol® (cisplatin ...
Gemzar®/Paraplatin® Followed by Taxol®/Paraplatin® as Initial ... Mar 28, 2006
Cancer Consultants (press release), According to an article recently published in the journal Gynecologic Oncology, the chemotherapy regimen consisting of Gemzar® (gemcitabine) plus Paraplatin ...
Point Therapeutics to Present at CIBC World Markets Annual ... Mar 29, 2006
Genetic Engineering News, ...cisplatin in metastatic melanoma, in combination with rituximab in advanced chronic lymphocytic leukemia, and in combination with gemcitabine in metastatic ...
UM students will present research in Lansing Mar 20, 2006
U of M News Service (press release), Another student tracks the actions of Gemcitabine, a chemotherapeutic drug used in pancreatic, non-small cell lung and breast cancer patients. ...
Taxotere® plus Gemzar® Provides AntiCancer Responses in ... Mar 29, 2006
Cancer Consultants (press release), ...in the International Journal of Cancer, the combination consisting of chemotherapy agents Taxotere® (docetaxel) and Gemzar® (gemcitabine) provides anticancer ...
Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2005 ... Mar 1, 2006
MSN Money ...of glufosfamide for the second-line treatment of patients with pancreatic cancer and a Phase 2 study of glufosfamide in combination with gemcitabine for first ...
Updated Guidelines for Treatment of Ovarian Cancer Mar 27, 2006
Cancer Consultants (press release), ...six months after stopping chemotherapy, the following chemotherapy regimens were added as treatment options: Gemzar® (gemcitabine)/Paraplatin® (carboplatin ...
Between 2010 and 2015 the Therapeutic Lung Cancer Drug Market is ... Mar 25, 2006
New Age Media Concepts (press release) ...chemotherapy drugs go off patent before 2012; Aventisi Taxotere (docetaxel), Bristol-Myers Squibbis Paraplatin (carboplatin) and Eli Lillyis Gemzar (gemcitabine ...
Lilly says hands off Gemzar Mar 14, 2006
Indianapolis Business Journal, ...based Sicor had filed so-called "abbreviated new drug applications" with the US Food and Drug Administration to market doses of gemcitabine, the compound that ...
Allos Therapeutics Reports 2005 Financial Results Mar 6, 2006
MSN Money ...the Company announced the publication of results from a pre-clinical study designed to compare the activity of a pralatrexate/gemcitabine combination relative ...
GenVec expands pancreatic cancer study Mar 16, 2006
Pharmaceutical Business Review ...and radiation therapy for five weeks, with or without a weekly intratumoral injection of TNFerade, followed by maintenance therapy (gemcitabine with or without ...
Gemzar Narrow Progression-Free Survival Benefit To Test Oncology ... Mar 10, 2006
FDA Advisory Committee In a pivotal trial comparing Gemzar plus carboplatin to carboplatin alone in 356 advanced ovarian cancer patients, the gemcitabine-containing regimen was ...
Tomudex® Plus Eloxatin® Effective in Gemzar®-Resistant ... Mar 24, 2006
Cancer Consultants (press release), Researchers from Italy have reported that approximately 50% of patients with metastatic pancreatic cancer who have failed Gemzar (gemcitabine) based regimens ...
Tomudex® Plus Eloxatin® Effective in Gemzar®-Resistant ... Mar 23, 2006
Cancer Consultants (press release), ...and Eloxatin® (oxaliplatin) provides benefit to some patients with metastatic pancreatic cancer that has stopped responding to Gemzar® (gemcitabine). ...
FDA Panel Recommends Rejection of Eli Lilly Drug Gemzar To Treat ... Mar 14, 2006
Kaiser network.org, FDA's Oncologic Drugs Advisory Committee found that data provided by Lilly on the use of Gemzar, known generically as gemcitabine, for advanced ovarian cancer ...
Point Therapeutics Reports Fourth Quarter and Year-End 2005 ... Mar 14, 2006
Genetic Engineering News, Initiated a 60 patient Phase 2 clinical trial of talabostat in combination with gemcitabine for the treatment of metastatic pancreatic cancer. ...
NCCN Announces Important Updates to Ovarian Cancer Clinical ... Mar 6, 2006
Genetic Engineering News, The regimens include gemcitabine (Gemzar, Lilly)/carboplatin (Paraplatin, Bristol Myers-Squibb) and carboplatin/paclitaxel (Taxol, Bristol Myers-Squibb). ...
US Advisers Against New Indication for Gemzar Mar 15, 2006
Cancerpage.com, 2006 (Reuters) - Advisers to the US Food and Drug Administration recommended on Monday against approving Eli Lilly & Co.'s Gemzar (gemcitabine/paclitaxel) to ...
Eli Lilly: Gemzar set for FDA rebuff Mar 14, 2006
Pharmaceutical Business Review Eli Lilly is seeking approval for Gemzar (gemcitabine) based on results from a pivotal phase III clinical trial, which randomized 365 advanced ovarian cancer ...
Millennium and Johnson & Johnson Pharmaceutical Research & ... Mar 6, 2006
PR Newswire (press release), ...clinical trial results of VELCADE in NSCLC include: * Interim survival data from a Phase II study of VELCADE in combination with gemcitabine and carboplatin in ...
Lilly Launches Phase III Trial of Targeted Cancer Agent Mar 9, 2006
news aktuell (Pressemitteilung), Alimta(R) (pemetrexed, Eli Lilly and Company) Gemzar(R) (gemcitabine HCl, Eli Lilly and Company) CeeNU(R) (lomustine [CCNU], Bristol Myers Squibb) (Logo: http ...
Sorafenib Shows Benefits in Combination with Gemcitabine in ... Nov 22, 2005
DG News PA -- November 22, 2005 -- A phase 2 study is evaluating the efficacy and toxicity associated with the use of sorafenib plus gemcitabine in patients with ...
Erbitux® Plus Gemzar®/Paraplatin® Promising for Stage IV NSCLC Dec 19, 2005
Cancer Consultants (press release), ...article published in the Journal of Clinical Oncology, the treatment combination consisting of Erbitux (cetuximab) plus Gemzar (gemcitabine) and Paraplatin ...
New therapy for pancreas cancer approved Dec 10, 2005
Daily News Journal (subscription), The FDA approved the addition of the targeted agent erlotinib (marketed as Tarceva) to the chemotherapy drug gemcitabine, which has been the only approved ...
New Treatment for Pancreatic Cancer Allows Life-Saving Surgery Dec 6, 2005
Newswise (press release) In the Norris Cotton Cancer Center trial, 24 patients were treated with short course, high dose chemotherapy of docetaxel and gemcitabine, followed by a ...
Human Genome Sciences Reports Interim Results of Phase 1b Clinical ... Nov 17, 2005
PR Newswire (press release), ...for use in a population pharmacokinetic (PK) analysis, to assess the impact of HGS-ETR1 co- administration on plasma concentrations of gemcitabine and cisplatin ...
I've heard the mistletoe may help fight cancer. Is this true? Dec 14, 2005
MayoClinic.com ...currently conducting a study to examine the safety and effectiveness of mistletoe injections, given in combination with the chemotherapy drug gemcitabine, as a ...
Induction Chemotherapy and Concomitant Chemoradiotherapy Promising ... Dec 6, 2005
Cancer Consultants (press release), ...the University of Alabama reported a 3-year survival rate of 45% in patients with stage III NSCLC treated with induction Gemzar® (gemcitabine) and Platinol ...
(PRN) US Oncology Research Network Presenting Numerous Studies at ... Dec 11, 2005
Houston Chronicle, Center. Phase II trial of gemcitabine plus carboplatin (plus trastuzumab in HER2+ subjects) in metastatic breast cancer patients. ...
Point Therapeutics Announces Positive Interim Results at American ... Dec 12, 2005
Business Wire (press release), ...cisplatin in metastatic melanoma, in combination with rituximab in advanced chronic lymphocytic leukemia, and in combination with gemcitabine in metastatic ...
Investigational Targeted Therapy May Offer Progress for Non ... Dec 10, 2005
PR Newswire (press release), Foundation, February 2005, http://www.lymphoma.org (November 9, 2005) ---- Gemzar(R) (gemcitabine, Eli Lilly and ...
Chemoradiation Shrinks Pancreatic Tumors to Operable Size Dec 8, 2005
MedPage Today, The trial tested a high-dose Taxotere (docetaxel) and Gemzar (gemcitabine) combination followed by twice-weekly Gemzar and external beam radiotherapy for six ...
Combination chemotherapies slow small cell lung cancer and cancer ... Nov 30, 2005
PharmaLive.com (press release), II trial led by Dr. John D. Hainsworth, SCRI director of clinical research, to evaluate the activity of combination chemotherapy of gemcitabine and irinotecan ...
Investigational Targeted Therapy May Offer Progress For Non ... Dec 10, 2005
news aktuell (Pressemitteilung), Gemzar(R) (gemcitabine, Eli Lilly and Company) Alimta(R) (pemetrexed, Eli Lilly and Company) (1)Lymphoma Research Foundation, "Learning About Lymphoma ...
Induction Chemotherapy Promising in Stage III Non-Small Cell Lung ... Dec 2, 2005
Cancer Consultants (press release), NSCLC. The median age of the patients was 59 years. Induction chemotherapy involved three cycles of gemcitabine and vinorelbine. This ...
AEterna Zentaris appoints a Board Vice Chairman, a New Chair of ... Nov 21, 2005
Yahoo! News (press release) ...drug development, he was involved in the early development of many of the agents now used routinely, including: Paclitaxel, Docetaxel, Gemcitabine, CPT-11 ...
Transgene: Clinical Pipeline Update Nov 30, 2005
Biotech Intelligence (press release), This trial is a randomized, open label and controlled study designed to assess the efficacy of TG4010 in combination with cisplatin and gemcitabine compared to ...
Being in dark on pancreatic cancer is deadly Nov 28, 2005
Fort Wayne Journal Gazette, Dorothy underwent a series of treatments, including Gemcitabine, her primary treatment, and later two clinical trials – Avastin, which was approved for ...
Human Genome Sciences Reports Results of Phase 1 Clinical Trials ... Nov 17, 2005
PR Newswire (press release), A Phase 1 study of HGS-ETR1, a fully human monoclonal antibody to TRAIL-R1, in combination with gemcitabine and cisplatin in subjects with advanced solid ...
|
|
